Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yingsheng Biotechnology is a leading Chinese developer of clinical mass spectrometry platforms and gene testing solutions. Its products include high-performance liquid chromatography-tandem mass spectrometers, neonatal genetic/metabolic disease screening kits, vitamin quantification kits, deafness gene tests, TDM reagents, and COVID nucleic acid test kits. The company has over a decade of experience with more than twenty national patents granted. No direct information about clinical trial results as it is primarily a diagnostics provider.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yingsheng Biotechnology.